We are live on
!
Find out more
WT
Wellcome Trust Portfolio holdings
AUM
$9.01B
1-Year Est. Return
12.05%
This Fund
S&P 500
This Quarter
Est. Return
+7.46%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$6.76B
AUM Growth
+$381M
(+6%)
Cap. Flow
+$25M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
60.09%
Holding
22
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$25M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.42% |
| 2 | Consumer Discretionary | 21.49% |
| 3 | Financials | 16.12% |
| 4 | Healthcare | 10.31% |
| 5 | Communication Services | 9.9% |
Similar funds
A
VAS
AI
AI
HI
SFM
MIH
RWP
Wellcome Trust's Q4 2022 Portfolio in Review
As of Q4 2022, Wellcome Trust held 22 positions worth $6.76B, up 6% from $6.38B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Wellcome Trust opened no new positions and made no exits, leaving the 22-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- Wellcome Trust added most to Edwards Lifesciences in Q4 2022, an estimated $25M increase.
- Wellcome Trust's ten largest holdings make up 60% of its $6.76B portfolio in Q4 2022.
- Wellcome Trust opened 0 new positions and closed 0 in Q4 2022.
- Wellcome Trust's portfolio value rose 6% quarter-over-quarter to $6.76B.
Based on Wellcome Trust's 13F filing for Q4 2022, filed 11 Jan 2023.